Titan Biotech Limited (TITANBIO.BO)
INR 456.8
(-0.87%)
INR 456.8
(-0.87%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 360.29 Million INR | 8.96% |
| 2022 | 314.62 Million INR | -25.12% |
| 2021 | 322.1 Million INR | -10.85% |
| 2020 | 464.02 Million INR | 244.33% |
| 2019 | 145.43 Million INR | 42.21% |
| 2018 | 95.48 Million INR | 32.43% |
| 2017 | 74.23 Million INR | 31.12% |
| 2016 | 56.53 Million INR | 33.29% |
| 2015 | 44.19 Million INR | 0.04% |
| 2014 | 42.88 Million INR | 22.13% |
| 2013 | 34.55 Million INR | 20.15% |
| 2012 | 26.95 Million INR | 22.29% |
| 2011 | 23.24 Million INR | 18.94% |
| 2010 | 19.47 Million INR | 23.99% |
| 2009 | 15.7 Million INR | 10.43% |
| 2008 | 14.22 Million INR | 6.21% |
| 2007 | 13.39 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 82.49 Million INR | 17.44% |
| 2023 Q2 | 92.65 Million INR | 13.42% |
| 2023 Q1 | 81.69 Million INR | 11.54% |
| 2023 Q4 | 70.78 Million INR | -35.88% |
| 2023 FY | - INR | 8.96% |
| 2023 Q3 | 110.39 Million INR | 19.14% |
| 2022 Q3 | 44.17 Million INR | -61.04% |
| 2022 Q4 | 73.24 Million INR | 65.79% |
| 2022 FY | - INR | -25.12% |
| 2022 Q1 | 83.82 Million INR | 9.9% |
| 2022 Q2 | 113.37 Million INR | 35.25% |
| 2021 Q1 | 145.5 Million INR | 87.84% |
| 2021 FY | - INR | -10.85% |
| 2021 Q2 | 107.33 Million INR | -26.24% |
| 2021 Q3 | 89.2 Million INR | -16.89% |
| 2021 Q4 | 76.27 Million INR | -14.49% |
| 2020 FY | - INR | 244.33% |
| 2020 Q2 | 110.7 Million INR | -45.12% |
| 2020 Q3 | 99.06 Million INR | -10.51% |
| 2020 Q4 | 77.46 Million INR | -21.81% |
| 2020 Q1 | 201.72 Million INR | 554.66% |
| 2019 FY | - INR | 42.21% |
| 2019 Q1 | 46.43 Million INR | 115.14% |
| 2019 Q2 | 26.58 Million INR | -42.75% |
| 2019 Q3 | 32.78 Million INR | 23.31% |
| 2019 Q4 | 30.81 Million INR | -6.01% |
| 2018 Q3 | 24.03 Million INR | -9.11% |
| 2018 Q4 | 21.58 Million INR | -10.21% |
| 2018 Q2 | 26.44 Million INR | 9.32% |
| 2018 Q1 | 24.19 Million INR | 24.09% |
| 2018 FY | - INR | 32.43% |
| 2017 Q3 | 20.18 Million INR | -5.83% |
| 2017 FY | - INR | 31.12% |
| 2017 Q4 | 19.49 Million INR | -3.44% |
| 2017 Q2 | 21.43 Million INR | 39.37% |
| 2017 Q1 | 15.38 Million INR | -19.82% |
| 2016 Q4 | 19.18 Million INR | 44.27% |
| 2016 FY | - INR | 33.29% |
| 2016 Q1 | 11.16 Million INR | 23.72% |
| 2016 Q3 | 13.29 Million INR | 4.26% |
| 2016 Q2 | 12.75 Million INR | 14.29% |
| 2015 FY | - INR | 0.04% |
| 2015 Q4 | 9.02 Million INR | -12.36% |
| 2015 Q3 | 10.29 Million INR | -7.77% |
| 2015 Q2 | 11.16 Million INR | 12.81% |
| 2015 Q1 | 9.89 Million INR | -12.41% |
| 2014 Q1 | 9.6 Million INR | -1.39% |
| 2014 FY | - INR | 22.13% |
| 2014 Q3 | 9.45 Million INR | -14.94% |
| 2014 Q2 | 11.11 Million INR | 15.73% |
| 2014 Q4 | 11.29 Million INR | 19.5% |
| 2013 Q2 | 9.26 Million INR | 43.07% |
| 2013 Q4 | 9.73 Million INR | 13.82% |
| 2013 Q1 | 6.47 Million INR | -19.53% |
| 2013 Q3 | 8.55 Million INR | -7.7% |
| 2013 FY | - INR | 20.15% |
| 2012 Q4 | 8.04 Million INR | 34.75% |
| 2012 Q1 | 6.28 Million INR | 40.84% |
| 2012 Q2 | 8.02 Million INR | 27.79% |
| 2012 Q3 | 5.97 Million INR | -25.56% |
| 2012 FY | - INR | 22.29% |
| 2011 Q4 | 4.45 Million INR | -26.95% |
| 2011 Q3 | 6.1 Million INR | 0.0% |
| 2011 FY | - INR | 18.94% |
| 2010 Q4 | 4.85 Million INR | 0.0% |
| 2010 FY | - INR | 23.99% |
| 2009 FY | - INR | 10.43% |
| 2008 FY | - INR | 6.21% |
| 2008 Q4 | 2.34 Million INR | 0.0% |
| 2007 FY | - INR | 0.0% |
| 2007 Q4 | 3.01 Million INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 10.12 Million INR | -3458.831% |
| Biocon Limited | 41.52 Billion INR | 99.132% |
| Blue Jet Healthcare Limited | 2.29 Billion INR | 84.282% |
| Concord Biotech Limited | 4.65 Billion INR | 92.267% |
| Dishman Carbogen Amcis Limited | 3.07 Billion INR | 88.271% |
| FERMENTA BIOTECH LIMITED | 262.68 Million INR | -37.161% |
| GENOMIC VALLEY BIOTECH LIMITED | 147.4 Thousand INR | -244330.876% |
| Lyka Labs Limited | 167.58 Million INR | -114.988% |
| Panacea Biotec Limited | -200.6 Million INR | 279.609% |
| SAMSRITA LABS LIMITED | -2.46 Million INR | 14743.5% |
| Servoteach Industries Limited | - INR | -Infinity% |
| SMS Lifesciences India Limited | 349.41 Million INR | -3.116% |
| Supriya Lifescience Limited | 1.83 Billion INR | 80.373% |
| Syngene International Limited | 10.84 Billion INR | 96.678% |
| TAKE Solutions Limited | -1.05 Billion INR | 134.286% |
| Transgene Biotek Limited | -4.33 Million INR | 8403.664% |
| Vanta Bioscience Limited | 14.19 Million INR | -2438.905% |